I started writing for SynBioBeta in 2018 covering aspects of the UK synthetic biology scene.
Most of my articles with SynBioBeta are linked here.


UKI2S are an investment fund specialising in synthetic biology start-ups in the UK. They were looking to start develop their blog and, after a lovely chat with their marketing lead, I wrote several blogs over a six-month period. Links to my pieces below.

Eagle Genomics Gains Microsoft Co-Sell Status for Microbiome Mapping AI Platform
A Fork in the Road: Quethera’s Story
UKI2S Synbio Digest
Funding Boost for Fusion
Crescendo Biologics lives up to its name
UKI2S Science Digest
Eastern Biopharma Industry and Investment
Tech to Watch 2019 – The Microbiome
Tech to Watch 2019 – AI
EPSRC Announces £440m for Doctoral Training
Life, but not as you know it.

Laboratory News was kind enough to let me publish a piece with my colleague Ben Bradley on the human gut microbiome, back when I did comms for CHAIN Biotech.

You can read the piece here.